← Browse by Condition
Medical Condition
resectable pancreatic cancer
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2
NCT05624918 Phase 2
Recruiting
A Study of NovoTTF-200T(P) in Combination With Gemcitabine and Nab-Paclitaxel for Resectable Pancreatic Adenocarcinoma
Enrollment
38 pts
Location
United States
Sponsor
Ashish Manne
NCT07022015
Recruiting
Predictive Risk Factors for Pancreatic Fistula After Pancreaticoduodenectomy
Enrollment
100 pts
Location
Egypt
Sponsor
Minia University